Very recently, Ravussin et al
Within hours of the patent expiry of Ozempic on March 20, at least nine copycat versions of semaglutide were launched, signalling what could become the worlds most competitive and affordable market for blockbuster obesity and diabetes drugs
In contrast, the weight loss effect of GLP-1 drugs is more pronounced
Some people may have other conditions, like metabolic liver disease or kidney issues, which retatrutide is being studied for, so these could impact the doctors recommendation
Compared to individuals with obesity of other etiologies matched for BMI (body mass index), they have lower levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides
Ensure that youre keeping your expectations realistic and that youre focused on sustainable weight loss and healthy lifestyle habits as you move through your treatment